专利信息

首页 1 2 3 4 5 6 下页尾页共 112 条记录, 当前第1/12页。

专利标题：PROCESS FOR PREPARING [4,6-BIS-DIMETHYLAMINO-2-[4-(4-TRIFLUOROMETHYLBENZOYL-AMINO)BENZYL]PYRIMIDIN-5-YL]ACETIC ACID

专利权人：BOEHRINGER INGELHEIM INT [DE];

专利标题：TIOTROPIUM SALTS, PHARMACEUTICAL FORMULATIONS CONTAINING THE SALTS AND THE USE THEREOF

专利权人：BOEHRINGER INGELHEIM INT [DE];

专利标题：CRYSTALLINE TIOTROPIUM IODIDE, THE PHARMACEUTICAL FORMULATION CONTAINING THE SAME AND THE USE THEREOF

专利权人：BOEHRINGER INGELHEIM INT [DE];

专利标题：BILAYER TABLET COMPRISING TELMISARTAN AND AMLODIPINE

专利权人：BOEHRINGER INGELHEIM INT [DE];

专利标题：COMBINATION OF CD37 ANTIBODIES WITH ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE)

专利权人：BOEHRINGER INGELHEIM INT [DE];

The present invention relates to immunotherapies that are based on depletion of CD37- positive cells such as B-cells. The present invention provides methods for reduction of CD37-positive cells such as B-cells in an individual / patient using a combination of CD37 antibody /antibodies and ICE. The combination of CD37 antibodies and ICEis shown to have improved anti-tumor efficacy compared to single agent treatment. The application further provides materials and methods for treatment of diseases ...

专利标题：Medicament combinations containing a 4h-benzo[ 1,4]oxaxin -3-one derivative and a tiotropium salt and their use in the manufacture of medicaments for the treatment of respiratory disorders

专利权人：BOEHRINGER INGELHEIM INT [DE];

专利标题：Process for the production of Telmisartan

专利标题：VOLASERTIB ALONE OR IN COMBINATION WITH CYTARABINE FOR TREATING ACUTE MYELOID LEUKEMIA

专利权人：BOEHRINGER INGELHEIM INT [DE];

专利标题：COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUBGENOTYPE SUB-POPULATION

专利权人：BOEHRINGER INGELHEIM INT [DE];

The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in patients having genetic variations located near the IL28B gene,...

专利标题：ORAL COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUB-POPULATION

The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) Compound (2), or a pharmaceutically acceptable salt thereof, as herein described, and optionally (c) ribavirin, and methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient having compensated liver disease.

当前查询条件: [专利权人] 包含 'BOEHRINGER INGELHEIM INT [DE]'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. EP2709988A1	2014/3/26	EP20120718262	2012/5/7
专利标题：PROCESS FOR PREPARING [4,6-BIS-DIMETHYLAMINO-2-[4-(4-TRIFLUOROMETHYLBENZOYL-AMINO)BENZYL]PYRIMIDIN-5-YL]ACETIC ACID 专利权人：BOEHRINGER INGELHEIM INT [DE];

2. HK1129111A1	2014/3/14	HK20090108607	2007/5/25
专利标题：TIOTROPIUM SALTS, PHARMACEUTICAL FORMULATIONS CONTAINING THE SALTS AND THE USE THEREOF 专利权人：BOEHRINGER INGELHEIM INT [DE];

3. HK1153409A1	2014/1/17	HK20110107748	2011/7/26
专利标题：CRYSTALLINE TIOTROPIUM IODIDE, THE PHARMACEUTICAL FORMULATION CONTAINING THE SAME AND THE USE THEREOF 专利权人：BOEHRINGER INGELHEIM INT [DE];

4. PT1814527E	2014/1/16	PT20050810652T	2005/10/29
专利标题：BILAYER TABLET COMPRISING TELMISARTAN AND AMLODIPINE 专利权人：BOEHRINGER INGELHEIM INT [DE];

5. WO2013171287A1	2013/11/21	WO2013EP60098	2013/5/15
专利标题：COMBINATION OF CD37 ANTIBODIES WITH ICE (IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE) 专利权人：BOEHRINGER INGELHEIM INT [DE]; The present invention relates to immunotherapies that are based on depletion of CD37- positive cells such as B-cells. The present invention provides methods for reduction of CD37-positive cells such as B-cells in an individual / patient using a combination of CD37 antibody /antibodies and ICE. The combination of CD37 antibodies and ICEis shown to have improved anti-tumor efficacy compared to single agent treatment. The application further provides materials and methods for treatment of diseases ...

6. IL190652A	2013/10/31	IL20080190652	2008/4/7
专利标题：Medicament combinations containing a 4h-benzo[ 1,4]oxaxin -3-one derivative and a tiotropium salt and their use in the manufacture of medicaments for the treatment of respiratory disorders 专利权人：BOEHRINGER INGELHEIM INT [DE];

7. SI2322511T1	2013/10/30	SI20040032083T	2004/3/26
专利标题：Process for the production of Telmisartan 专利权人：BOEHRINGER INGELHEIM INT [DE];BOEHRINGER INGELHEIM PHARMA [DE];

8. EP2646033A1	2013/10/9	EP20110787895	2011/11/25
专利标题：VOLASERTIB ALONE OR IN COMBINATION WITH CYTARABINE FOR TREATING ACUTE MYELOID LEUKEMIA 专利权人：BOEHRINGER INGELHEIM INT [DE];

9. WO2013144193A1	2013/10/3	WO2013EP56499	2013/3/27
专利标题：COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUBGENOTYPE SUB-POPULATION 专利权人：BOEHRINGER INGELHEIM INT [DE]; The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) an interferon alfa and (c) ribavirin. Compound (1) is a selective and potent inhibitor of the HCV NS3 serine protease. The present invention also relates to methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in patients having genetic variations located near the IL28B gene,...

10. WO2013147750A1	2013/10/3	WO2012US30698	2012/3/27
专利标题：ORAL COMBINATION THERAPY FOR TREATING HCV INFECTION IN SPECIFIC PATIENT SUB-POPULATION 专利权人：BOEHRINGER INGELHEIM INT [DE];MENSA FEDERICO [US]; The present invention relates to therapeutic combinations comprising (a) Compound (1), or a pharmaceutically acceptable salt thereof, as herein described, (b) Compound (2), or a pharmaceutically acceptable salt thereof, as herein described, and optionally (c) ribavirin, and methods of using such therapeutic combinations for treating HCV infection or alleviating one or more symptoms thereof in a patient having compensated liver disease.

下载范围

下载内容